UPDATE : Tuesday, October 15, 2019
상단여백
‘Kosdaq firms listed for exceptional tech need special monitoring’ by Jeong Sae-im 2019-10-07 15:51
Regulator remains unclear on who got Allergan's breast implant by Lee Han-soo 2019-10-07 14:58
Sanofi confirms prolonged PFS in patients with advanced gastric cancer by Lee Han-soo 2019-10-07 14:39
Galderma Korea workers feel insecure after separation from Nestle by Kim Yun-mi 2019-10-07 14:38
SK Plasma launches human immunoglobulin in Brazil by Lee Han-soo 2019-10-07 11:23
라인
Albis most prescribed ranitidine drug with carcinogen risk by Kwak Sung-sun 2019-10-07 11:23
Qurient sets up joint firm with Nobel chemistry prize winner by Lee Han-soo 2019-10-04 17:45
Lilly's Verzenio extends life for women with advanced breast cancer by Lee Han-soo 2019-10-04 16:15
‘New law to support advanced biopharmaceuticals, ensure safety’ by Lee Hye-seon 2019-10-04 15:18
Regulator under fire for neglecting reported side effects of Invossa by Lee Han-soo 2019-10-04 14:59
라인
Severance confirms efficacy, safety of Yuhan's lung cancer drug Lazertinib by Lee Han-soo 2019-10-04 14:39
Samsung execs pass buck to biotech subsidiaries for destroying evidence by Jeong Sae-im 2019-10-04 11:42
Foreign patients visiting Korea rise by 17.8% in 2018 by Lee Han-soo 2019-10-02 17:50
Eisai’s hepatocellular carcinoma treatment Lenvima to get insurance benefit by Lee Han-soo 2019-10-02 16:10
CDK4/6 inhibitor+fulvestrant combo nears getting benefit by Kim Yun-mi 2019-10-02 16:03
라인
Daewoong's EU partner wins sales approval for BTX by Lee Han-soo 2019-10-02 14:51
Authorities to test drugs of ranitidine family for carcinogen risk by Lee Hye-seon 2019-10-02 14:51
Anorexia craze among Korean girls raises concerns by Lee Han-soo 2019-10-02 11:34
Regulator raids cell therapy makers too often to little avail by Jeong Sae-im 2019-10-02 11:23
Daewoong's reaffirms drug-marketing power with Daiichi Sankyo's NOAC treatment by Lee Han-soo 2019-10-01 16:43
여백
여백
여백
Back to Top